Submitted by Anonymous (not verified) on 24 June 2025 - 14:50
Human medicines European public assessment report (EPAR): Jemperli, dostarlimab, Date of authorisation: 21/04/2021, Revision: 12, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Jemperli, dostarlimab, Date of authorisation: 21/04/2021, Revision: 12, Status: Authorised